Skip to main content
. 2017 Oct 9;8:147–159. doi: 10.2147/LCTT.S117944

Figure 1.

Figure 1

Molecular targets of EGFR inhibitors (A); exon map of EGFR mutations (B).

Abbreviation: TKI, tyrosine-kinase inhibitor.